JMJD1C
protein-codingjumonji domain containing 1C, the group of Lysine demethylases|MicroRNA protein coding host genes
Gene summary
The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
- TRIP8
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~354.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0001071
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018923
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: G2P
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to JMJD1C variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_032776.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 363 | 17 | 383 | ||
| missense | 1 | 953 | 52 | 7 | 1013 | |
| nonsense | 6 | 6 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 8 | 10 | |||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 2 | 1 | 980 | 415 | 24 | 1422 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_116165.1 | 26 | MANE Select | |
| Ensembl | ENSP00000382204.2 | 26 | MANE Select | |
| RefSeq | NP_001269877.1 | 23 | Standard | |
| RefSeq | NP_001305082.1 | 20 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| jmjd1cb | Danio rerio | Structure: myeloid cell development Quality: absent abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Transcriptional misregulation in cancer - Homo sapiens (human)
- Pathways Affected in Adenoid Cystic Carcinoma
- Factors involved in megakaryocyte development and platelet production
- Hemostasis
Biological Process
- regulation of transcription, DNA-templated
- blood coagulation
- histone H3-K9 demethylation
- oxidation-reduction process
Molecular Function
- transcription regulatory region sequence-specific DNA binding
- protein binding
- chromatin DNA binding
- histone demethylase activity (H3-K9 specific)
- metal ion binding
Cellular Component
- chromatin
- nucleus
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000399262
- Coding exons
- 26
- Length
- 298742
- Individuals with no LoFs
- 124790
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 11
- Defined
- 124801
- p
- 0.0000441
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.51 | 1138 | 1.29e+3 | 0.881 | 0.0000630 | 16782 |
| Missense (PolyPhen) | 270 | 478.95 | 0.56373 | 6199 | ||
| Synonymous | -1.81 | 495 | 446 | 1.11 | 0.0000214 | 4741 |
| Loss of Function | 9.35 | 3 | 108 | 0.0278 | 0.00000544 | 1415 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000090 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.000056 | 0.000056 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000028 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00050 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May be involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- LoFtool
- 0.0285
- RVIS EVS
- -0.55
- RVIS percentile EVS
- 19.81
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.836
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |